Phenominer Database Results (32 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
DA.PVG.1AV1-(D4Got60-D4Kini1)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 38 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 24 33.0 d in vivo visual assessment 0.0 subcutaneous injection from 8 to38 days 69382 892
DA.PVG.1AV1-(D4Got211-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 16 33.9 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 40 days 69388 892
DA.PVG.1AV1-(D4Rat23-D4Rat108)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 7 16.3 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 40 days 69413 892
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 10 14.1 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 40 days 69410 892
DA.PVG.1AV1-(D4Rat231-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 14 28.9 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 34 days 69433 892
DA.ACI-(D10Rat2-D10Rat29)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. central nervous system integrity trait male 103.0 days-131.0 days 3 14.7 d 1.44 2.5 in vivo visual assessment 0.0 intradermal injection from p.i. day 7 68719 839
DA.ACI-(D10Rat2-D10Rat29)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. central nervous system integrity trait male 103.0 days-131.0 days 1 23.0 d in vivo visual assessment 0.0 intradermal injection from p.i. day 7 68727 839
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 16 33.8 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 40 days 69385 892
DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 40 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 14 11.2 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 40 days 69416 892
DA.PVG.1AV1-(D4Rat103-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 28 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 19 17.3 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 28 days 69420 892
DA.PVG.1AV1-(D4Rat23-D4Rat108)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 10 32.8 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 34 days 69427 892
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (30 ug) and Freund's incomplete adjuvant (100 ul) Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. central nervous system integrity trait male 65.0 days-112.0 days 22 19.6 d 2.22 10.4 in vivo visual assessment 0.0 69493 837
DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (30 ug) and Freund's incomplete adjuvant (100 ul) Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. central nervous system integrity trait male 65.0 days-112.0 days 21 21.9 d 2.47 11.3 in vivo visual assessment 0.0 69494 837
DA.PVG.1AV1-(D4Rat23-D4Rat108)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 31 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 10 18.2 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 31days 69395 892
DA.PVG.1AV1-(D4Got60-D4Kini1)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 38 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 11 17.4 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 38days 69407 892
DA.PVG.1AV1-(D4Rat231-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 28 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 21 16.2 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 28 days 69422 892
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. central nervous system integrity trait male 103.0 days-131.0 days 8 16.2 d 0.92 2.6 in vivo visual assessment 0.0 intradermal injection from p.i. day 7 68707 839
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 37 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 28 26.5 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 37 days 69380 892
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 17 25.2 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 34 days 69424 892
DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 18 31.2 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 34 days 69429 892
DA.PVG.1AV1-(D4Got60-D4Kini1)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 6 28.3 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 34 days 69436 892
DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (15-20 ug) and Freund's incomplete adjuvant (100 ul) Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. central nervous system integrity trait female 65.0 days-112.0 days 13 22.5 d 3.58 12.9 in vivo visual assessment 0.0 69492 837
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (15-20 ug) and Freund's incomplete adjuvant (100 ul) Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. central nervous system integrity trait female 65.0 days-112.0 days 12 14.8 d 2.4 8.3 in vivo visual assessment 0.0 69491 837
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (0.09 ug/g) and Freund's incomplete adjuvant (100 ul) Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. central nervous system integrity trait female 65.0 days-112.0 days 15.6 d 9.4 in vivo visual assessment 0.0 69499 837
DA.PVG.1AV1-(D17Rat8-D17Rat37)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (0.1 ug/g) and Freund's incomplete adjuvant (100 ul) Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. central nervous system integrity trait female 65.0 days-112.0 days 22.5 d 12.9 in vivo visual assessment 0.0 69500 837
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. central nervous system integrity trait male 103.0 days-131.0 days 11 14.9 d 1.03 3.4 in vivo visual assessment 0.0 intradermal injection from p.i. day 7 68133 839
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. central nervous system integrity trait male 103.0 days-131.0 days 6 21.2 d 0.53 1.3 in vivo visual assessment 0.0 intradermal injection from p.i. day 7 68711 839
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. central nervous system integrity trait male 103.0 days-131.0 days 8 19.2 d 1.24 3.5 in vivo visual assessment 0.0 intradermal injection from p.i. day 7 68715 839
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 38 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 18 16.7 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 38 days 69391 892
DA.PVG.1AV1-(D4Got211-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 31 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 19 15.8 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 31days days 69398 892
DA/ZtmKini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 28 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 21 18.7 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 28 days 69418 892
DA.PVG.1AV1-(D4Rat103-D4Mit12)/Kini post-insult time to onset of experimental autoimmune encephalomyelitis myelin oligodendrocyte glycoprotein (13-85 ug/200 ul) (for 34 days) Marta M, et al., Genes Immun. 2010 Jan;11(1):21-36. Epub 2009 Aug 13. central nervous system integrity trait female  days 9 28.4 d in vivo visual assessment 0.0 subcutaneous injection from 8 to 34 days 69431 892